翻訳と辞書
Words near each other
・ Crivăț River
・ Crivăț River (Firiza)
・ Crivăț River (Ialomița)
・ Crivăț, Călărași
・ Crivățu
・ Crixus
・ Crixás
・ Crixás Açu River
・ Crixás do Tocantins
・ Crixás Mirim River
・ Crixás River
・ Crixás River (Goiás)
・ Crixás River (Tocantins)
・ Crizbav
・ Crizbav River
Crizotinib
・ Crizzly
・ Criș
・ Criș Collector Canal
・ Criș River (Târnava Mare tributary)
・ Crișan
・ Crișan (surname)
・ Crișan River
・ Crișan River (Chichirgeaua)
・ Crișan River (Galbena)
・ Crișan, Satu Mare
・ Crișan, Tulcea
・ Crișana
・ Crișana (disambiguation)
・ Crișana (newspaper)


Dictionary Lists
翻訳と辞書 辞書検索 [ 開発暫定版 ]
スポンサード リンク

Crizotinib : ウィキペディア英語版
Crizotinib

Crizotinib (trade name Xalkori, Pfizer), is an anti-cancer drug acting as an ALK (anaplastic lymphoma kinase) and ROS1 (c-ros oncogene 1) inhibitor, approved for treatment of some non-small cell lung carcinoma (NSCLC) in the US and some other countries, and undergoing clinical trials testing its safety and efficacy in anaplastic large cell lymphoma, neuroblastoma, and other advanced solid tumors in both adults and children.〔
== Mechanism of action ==

Crizotinib has an aminopyridine structure, and functions as a protein kinase inhibitor by competitive binding within the ATP-binding pocket of target kinases. About 4% of patients with non-small cell lung carcinoma have a chromosomal rearrangement that generates a fusion gene between ''EML4'' ('echinoderm microtubule-associated protein-like 4') and ''ALK'' ('anaplastic lymphoma kinase'), which results in constitutive kinase activity that contributes to carcinogenesis and seems to drive the malignant phenotype.〔 The kinase activity of the fusion protein is inhibited by crizotinib.〔 Patients with this gene fusion are typically younger non-smokers who do not have mutations in either the ''epidermal growth factor receptor'' gene (EGFR) or in the ''K-Ras'' gene.〔〔 The number of new cases of ''ALK''-fusion NSLC is about 9,000 per year in the U.S. and about 45,000 worldwide.〔〔
''ALK'' mutations are thought to be important in driving the malignant phenotype in about 15% of cases of neuroblastoma, a rare form of peripheral nervous system cancer that occurs almost exclusively in very young children.
Crizotinib inhibits the ''c-Met''/Hepatocyte growth factor receptor (HGFR) tyrosine kinase, which is involved in the oncogenesis of a number of other histological forms of malignant neoplasms.
Crizotinib is currently thought to exert its effects through modulation of the growth, migration, and invasion of malignant cells.〔 Other studies suggest that crizotinib might also act via inhibition of angiogenesis in malignant tumors.

抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)
ウィキペディアで「Crizotinib」の詳細全文を読む



スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース

Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.